Warning letter

ThermoLife International: warning letter of Jun 13, 2002

FDA warning letter UCM144970 · Center for Drug Evaluation and Research

Key facts

Reference number UCM144970
Company ThermoLife International
Subject Synthetic Ephedrine Alkaloids/New Drug
Issue date Jun 13, 2002
Posted date Jun 13, 2002
Issuing office Center for Drug Evaluation and Research
Product type Drugs
Country 3
Letter on fda.gov web.archive.org

About FDA warning letters

FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.

Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date:

Browse all FDA warning letters